Skip to main content


Fig. 3 | Alzheimer's Research & Therapy

Fig. 3

From: What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink

Fig. 3

Indicative graph of N-methyl-d-aspartate (NMDA) receptor antagonist prescriptions in patients with probable Alzheimer’s disease. This graph shows the proportion of patients with probable Alzheimer’s disease receiving their first prescription for an NMDA receptor antagonist each month from January 2003 to December 2015. The fixed lines indicate events with the potential to affect prescription rates during the study period. The joinpoints, the monthly percent change (MPC) for each segment, and the average monthly percent change (AMPC) for the study period are also presented

Back to article page